AI-Enhanced Ex-Vivo Lung Perfusion System Innovation

Current organ preservation techniques, as described in the original patent, are limited by their reliance on hypothermic storage and chemical perfusion solutions. The present invention addresses these limitations by introducing a paradigm shift in ex-vivo lung perfusion, enabling real-time adaptation to changing lung conditions, predictive analytics, and decentralized data tracking.

The present invention's novelty lies in the integration of artificial intelligence, machine learning, and bio-inspired materials to create a real-time adaptive ex-vivo lung perfusion system. The inventive step is the use of these technologies to overcome the limitations of current organ preservation techniques, enabling a paradigm shift in the field.

Alternative embodiments of the invention may include the use of different machine learning algorithms, varying types of bio-inspired materials, or alternative decentralized data tracking platforms. Variations of the invention could also include the application of these technologies to other organs or tissues, expanding the scope of the invention beyond lung perfusion.

The intelligent ex-vivo lung perfusion system has significant commercial potential in the organ transplantation and regenerative medicine industries, with potential applications in hospitals, research institutions, and biotechnology companies. The market for this technology is expected to grow as the demand for organ transplantation increases, driven by the rising need for effective organ preservation solutions.